Wissenschaftliche Arbeiten

Prof. Dr. Meral Beksaç

911 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation

    Transfusion Science, 1999

    DOI 10.1016/s0955-3886(98)00094-0 PMID 10621563 20 Zitationen (Europe PMC) Quelle: ORCID

  2. The influence of CD41+ and CD42+ peripheral blood stem cells on platelet engraftment after allo PBSCT

    Bone Marrow Transplantation, 1999

    Quelle: ORCID

  3. Treatment of acute and chronic graft versus host disease with mycophenolate mofetil

    Blood, 1999

    Quelle: ORCID

  4. Value of microvessel density(MVD) and vascular endothelial growth factor (VEGF) expression in adult acute myeloid (AML) leukemia before and after therapy

    Blood, 1999

    Quelle: ORCID

  5. Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia

    Bone Marrow Transplantation, 1998

    DOI 10.1038/sj.bmt.1701240 PMID 9645582 9 Zitationen (Europe PMC) Quelle: ORCID

  6. Allogeneic hematopoietic stem cell transplantation in patients with advanced hematological malignancies by using nonmyeloablative conditioning regimen

    Blood, 1998

    Quelle: ORCID

  7. Allogeneic peripheral blood stem cell transplantation in acute non- lymphoblastic leukemia

    Hematological Oncology, 1998

    DOI 10.1002/(sici)1099-1069(199812)16:4<155::aid-hon633>3.0.co;2-0 PMID 10414235 5 Zitationen (Europe PMC) Quelle: ORCID

  8. Allogeneic peripheral blood stem cell transplantation in leukemias:: A single center results

    Bone Marrow Transplantation, 1998

    Quelle: ORCID

  9. Allogeneic peripheral blood stem cell transplants cause more chronic graft versus host disease and less relapse compared to bone marrow transplants

    Bone Marrow Transplantation, 1998

    Quelle: ORCID

  10. An automated blood cell analysis and classification system

    Concurrent Systems Engineering Series, 1998

    Quelle: ORCID

  11. Circulating CD44 and ICAM-1 levels in low grade non-Hodgkin's lymphoma and B-CLL patients during interferon alpha-2A treatment

    Blood, 1998

    Quelle: ORCID

  12. Cladribine therapy in chronic lymphoproliferative disorders:: Single center experience

    British Journal of Haematology, 1998

    Quelle: ORCID

  13. Cord blood transplantation (CBT) in hemoglobinopathies

    Bone Marrow Transplantation, 1998

    27 Zitationen (OpenAlex) Quelle: ORCID

  14. Cord blood transplantation (CBT) in homozygous B-thalassemia (Hβth)

    Bone Marrow Transplantation, 1998

    Quelle: ORCID

  15. Effect of in vivo use of alltrans retinoic acid (ATRA) as a single agent on expression of BCL-2 and rhodamine uptake in patients with de novo acute myeloblastic leukemia

    Blood, 1998

    Quelle: ORCID

  16. European results of unrelated cord blood transplants

    Bone Marrow Transplantation, 1998

    18 Zitationen (OpenAlex) Quelle: ORCID

  17. Flow cytometric G-CSF receptor expression in acute myeloid leukemia and role in G-CSF use at induction chemotherapy

    British Journal of Haematology, 1998

    Quelle: ORCID

  18. Frequent demonstration of human herpesvirus 8(HHV-8) in bone marrow biopsy samples from Turkish patients with multiple myeloma (MM)

    Blood, 1998

    Quelle: ORCID

  19. Incidence of Tuberculosis after bone marrow transplantation in a single center from Turkey

    Haematologia, 1998

    Quelle: ORCID

  20. Increased CD38 expression on peripheral blood lymphocytes associate with more advanced disease and poor survival in multiple myeloma patients

    Blood, 1998

    Quelle: ORCID

  21. Interferon alpha 2a and low dose cytarabine in chronic myeloid leukemia:: Second interim analysis of multicenter study

    Blood, 1998

    Quelle: ORCID

  22. Intravesical tranexamic acid instillations for the treatment of hemorrhagic cystitis

    Bone Marrow Transplantation, 1998

    Quelle: ORCID

  23. Is there a relationship between G-CSF response to conditioning regimen and engraftment after bone marrow transplantation? [2]

    Bone Marrow Transplantation, 1998

    DOI 10.1038/sj.bmt.1701108 PMID 9535050 2 Zitationen (Europe PMC) Quelle: ORCID

  24. Randomised unicenter trial for comparison of three regimens in de novo adult acute nonlymphoblastic leukaemia

    Medical Oncology, 1998

    DOI 10.1007/bf02821937 PMID 9819795 7 Zitationen (Europe PMC) Quelle: ORCID

  25. Randomized unicenter trial for comparison of three regimens in de novo adult acute nonlymphoblastic leukemia

    British Journal of Haematology, 1998

    Quelle: ORCID

  26. Serum erythropoietin levels in patients with leukemia on cytostatic treatment

    Haematologia, 1998

    Quelle: ORCID

  27. Serum transforming growth factor beta 1 levels in multiple myeloma

    Blood, 1998

    Quelle: ORCID

  28. T-cell subsets in multiple myeloma:: Relation to clinical phase and stage of disease and prognosis

    Blood, 1998

    Quelle: ORCID

  29. The presence of clonal B cell excess as an indicator of advanced disease and poor survival in patients with multiple myeloma

    Blood, 1998

    Quelle: ORCID

  30. Which hematopoietic stem cell transplantation type is safe for patients with hepatitis B virus carriers

    Hepatology, 1998

    Quelle: ORCID

  31. Kemoterapi alan lösemili hastalarda serum eritropoietin düzeyleri

    DergiPark (Istanbul University), 1997

    Quelle: OpenAlex

  32. A case report of a patient who has pure red cell aplasia and rheumatoid arthritis

    International Journal of Hematology, 1997

    Quelle: ORCID

  33. A phase III, randomized multicenter study of induction with or without granulocyte colony stimulating factor (G-CSF) followed by intensive consolidation versus stem cell transplantation (PBSCT) in AML (preliminary results of Turkish Leukemia Study Group TLG95-002)

    Blood, 1997

    Quelle: ORCID

  34. A randomized single institutional study on comparison of idarubicin (I) versus daunorubicin (D) versus mitoxantrone (M) containing induction and consolidation regimens in acute myeloblastic leukemia (AML)

    Blood, 1997

    Quelle: ORCID

  35. Administration of MINE protocol in untreated patients with intermediate and high grade non-Hodgkin's lymphoma

    Haematologia, 1997

    PMID 9408764 1 Zitation (OpenAlex) Quelle: ORCID

  36. Allogeneic peripheral blood stem cell transplantation: Is there an increased risk of graft vs host disease in leukemia patients?

    Journal of Chemotherapy, 1997

    DOI 10.1179/joc.1997.9.5.371 PMID 9373793 1 Zitation (Europe PMC) Quelle: ORCID

  37. Clinical relevance of flow cytometric BCL-2 and CD95 expression in acute myeloid leukemia

    Blood, 1997

    Quelle: ORCID

  38. Cyclosporin-A combined with VAD vs VAD in patients with refractory multiple myeloma: An EORTC/HOVON randomized phase II study

    Blood, 1997

    Quelle: ORCID

  39. Determination of In Vitro drug sensitivity to a panel of cystostatic drugs and interferon alpha-2b in patients with renal cell carcinoma

    International Urology and Nephrology, 1997

    DOI 10.1007/bf02551107 PMID 9405998 1 Zitation (Europe PMC) Quelle: ORCID

  40. Donor leukocyte infusions for the treatment of leukemia relapse after allogeneic hematopoietic progenitor cell transplantation

    Blood, 1997

    Quelle: ORCID

  41. Factors affecting hematopoietic engraftment after peripheral blood stem cell transplantation with sufficient number of CD34 (+) cells infused

    Experimental Hematology, 1997

    Quelle: ORCID

  42. Febrile neutropenia in a bone marrow transplantation unit

    International Journal of Antimicrobial Agents, 1997

    DOI 10.1016/s0924-8579(96)00364-0 PMID 18611793 2 Zitationen (Europe PMC) Quelle: ORCID

  43. HLA DR2: A predictive marker in response to cyclosporine therapy in aplastic anemia

    International Journal of Hematology, 1997

    DOI 10.1016/s0925-5710(97)00054-6 PMID 9401274 14 Zitationen (Europe PMC) Quelle: ORCID

  44. Hematological and cytogenetic efficiency of interferon alpha 2a plus low dose cytarabine in chronic myelogenous leukemia: An interim analysis of multicenter study

    Blood, 1997

    Quelle: ORCID

  45. Hemorrhagic cystitis as a complication of bone marrow transplantation

    Journal of Chemotherapy, 1997

    DOI 10.1179/joc.1997.9.1.56 PMID 9106019 7 Zitationen (Europe PMC) Quelle: ORCID

  46. Hepatitis B virus infection in allogeneic bone marrow transplantation

    Bone Marrow Transplantation, 1997

    DOI 10.1038/sj.bmt.1700885 PMID 9285543 39 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  47. In vitro drug sensitivity testing of human testicular germ cell tumours with cytostatic drugs and interferon alpha-2b

    International Urology and Nephrology, 1997

    DOI 10.1007/bf02551421 PMID 9203042 1 Zitation (Europe PMC) Quelle: ORCID

  48. Incidence of graft vs host disease in allogeneic bone marrow transplantation in a single center study from Turkey

    Hematology and Cell Therapy, 1997

    DOI 10.1007/s00282-997-0133-1 PMID 9262989 2 Zitationen (Europe PMC) Quelle: ORCID

  49. Protein-C, protein-S, antithrombin-III levels after hematopoietic stem cell transplantation

    Thrombosis and Haemostasis, 1997

    Quelle: ORCID

  50. Randomized 3 arm phase III study of interleukin 3 (IL-3), or granulocyte/macrophage colony-stimulating factor (GM-CSF) as an adjuvant to low doses of cytosine arabinoside (LD-AraC) for the treatment of high-risk myelodysplastic syndromes (HR-MDS)

    Blood, 1997

    Quelle: ORCID